{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:44:06Z","timestamp":1787024646858,"version":"build-2736575974"},"reference-count":47,"publisher":"Bentham Science Publishers Ltd.","issue":"29","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPD"],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The clinical utility of Adriamycin (ADR) is limited due to its toxicity, particularly cardiotoxicity.\nTherefore, effective cardioprotective adjuvants to minimize ADR-induced acute cardiotoxicity are\nurgently needed. Our previous studies have demonstrated the protective roles of fasudil on tissue injury. Here,\nwe further explore whether inhibition of Rho-kinase could alleviate the acute heart injury induced by ADR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>C57BL6 mice were randomly divided into the following four groups: \u2460 ADR group; \u2461 low-dose\nfasudil (ADR+L); \u2462 high-dose fasudil (ADR+H); and \u2463 control group (CON). Animals were injected i.p 20\nmg\/kg ADR once in group \u2460~\u2462. Animals were injected i.p fasudil (2 or 10 mg\/kg\/day) daily for consecutive 6\ndays in groups \u2461 and \u2462, respectively. Blood samples and heart tissues were collected for assays. H9C2 cells\nwere treated with fasudil for 30 mins and then incubated with ADR for 24 hours. Cells were collected for immunohistochemistry\nand western blot study, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>In the mouse model, administration of fasudil significantly ameliorated ADR-induced cardiac damage,\nsuppressed cell apoptosis and senescence, and ameliorated redox imbalance and DNA damage. In vitro, fasudil\ntreatment ameliorated ADR-induced immunofluorescence reaction of 8-OHdG, decreased the expression of\nTUNEL cells and proteins of Bax, Caspase-3 and p53, and increased the expression of proteins of Bcl-2 and\nSIRT 1.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Fasudil has a protective effect on ADR induced acute cardiotoxicity, which is partially attributed\nto its antioxidant, anti-senescence, and anti-apoptotic effects.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/1381612828666220729103430","type":"journal-article","created":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:48:50Z","timestamp":1659314930000},"page":"2426-2435","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Fasudil Protects Against Adriamycin-induced Acute Heart Injury by Inhibiting\nOxidative Stress, Apoptosis, and Cellular Senescence"],"prefix":"10.2174","volume":"28","author":[{"given":"Yi","family":"Yan","sequence":"first","affiliation":[{"name":"Department of Cardiology, Jiangyin People\u2019s Hospital, Jiangyin, Jiangsu Province, P.R China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyu","family":"Xiang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The\nFirst Affiliated Hospital of Nanjing Medical University, Nangjing, Jiangsu Province, P.R China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingguo","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The\nFirst Affiliated Hospital of Nanjing Medical University, Nangjing, Jiangsu Province, P.R China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1161\/01.CIR.0000146889.46519.27","volume":"110","author":"Nozaki N.","year":"2004","unstructured":"Nozaki N.; Shishido T.; Takeishi Y.; Kubota I.; Modulation of doxorubicin-induced cardiac dysfunction in toll-like receptor-2-knockout mice. Circulation 2004,110(18),2869-2874","journal-title":"Circulation"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s12012-017-9420-4","volume":"18","author":"Zakaria N.","year":"2018","unstructured":"Zakaria N.; Khalil S.R.; Awad A.; Khairy G.M.; Quercetin reverses altered energy metabolism in the heart of rats receiving adriamycin chemotherapy. Cardiovasc Toxicol 2018,18(2),109-119","journal-title":"Cardiovasc Toxicol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1016\/j.fct.2011.06.080","volume":"49","author":"Wang N.","year":"2011","unstructured":"Wang N.; Guan P.; Zhang J.P.; Preventive effects of fasudil on adriamycin-induced cardiomyopathy: Possible involvement of inhibition of RhoA\/ROCK pathway. Food Chem Toxicol 2011,49(11),2975-2982","journal-title":"Food Chem Toxicol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"e0193918","DOI":"10.1371\/journal.pone.0193918","volume":"13","author":"Bose C.","year":"2018","unstructured":"Bose C.; Awasthi S.; Sharma R.; Sulforaphane potentiates anticancer effects of doxorubicin and attenuates its cardiotoxicity in a breast cancer model. PLoS One 2018,13(3),e0193918","journal-title":"PLoS One"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1016\/j.freeradbiomed.2010.08.005","volume":"49","author":"Thandavarayan R.A.","year":"2010","unstructured":"Thandavarayan R.A.; Watanabe K.; Sari F.R.; Modulation of doxorubicin-induced cardiac dysfunction in dominant-negative p38\u03b1 mitogen-activated protein kinase mice. Free Radic Biol Med 2010,49(9),1422-1431","journal-title":"Free Radic Biol Med"},{"key":"ref=6","first-page":"6139","volume":"22","author":"Dai G.F.","year":"2018","unstructured":"Dai G.F.; Wang Z.; Zhang J.Y.; Octreotide protects doxorubicin-induced cardiac toxicity via regulating oxidative stress. Eur Rev Med Pharmacol Sci 2018,22(18),6139-6148","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.yjmcc.2012.03.006","volume":"52","author":"Octavia Y.","year":"2012","unstructured":"Octavia Y.; Tocchetti C.G.; Gabrielson K.L.; Janssens S.; Crijns H.J.; Moens A.L.; Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies. J Mol Cell Cardiol 2012,52(6),1213-1225","journal-title":"J Mol Cell Cardiol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"19672","DOI":"10.1074\/jbc.RA118.004673","volume":"293","author":"Xia P.","year":"2018","unstructured":"Xia P.; Liu Y.; Chen J.; Coates S.; Liu D.X.; Cheng Z.; Inhibition of cyclin-dependent kinase 2 protects against doxorubicin-induced cardiomyocyte apoptosis and cardiomyopathy. J Biol Chem 2018,293(51),19672-19685","journal-title":"J Biol Chem"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1161\/01.CIR.102.17.2105","volume":"102","author":"Li T.","year":"2000","unstructured":"Li T.; Singal P.K.; Adriamycin-induced early changes in myocardial antioxidant enzymes and their modulation by probucol. Circulation 2000,102(17),2105-2110","journal-title":"Circulation"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.2174\/138161211796904812","volume":"17","author":"Pereira G.C.","year":"2011","unstructured":"Pereira G.C.; Silva A.M.; Diogo C.V.; Carvalho F.S.; Monteiro P.; Oliveira P.J.; Drug-induced cardiac mitochondrial toxicity and protection: From doxorubicin to carvedilol. Curr Pharm Des 2011,17(20),2113-2129","journal-title":"Curr Pharm Des"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.cbi.2019.03.012","volume":"304","author":"Fang J.","year":"2019","unstructured":"Fang J.; Tang Y.; Cheng X.; Exenatide alleviates adriamycin-induced heart dysfunction in mice: Modulation of oxidative stress, apoptosis and inflammation. Chem Biol Interact 2019,304,186-193","journal-title":"Chem Biol Interact"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.exger.2017.08.001","volume":"109","author":"Sung J.Y.","year":"2018","unstructured":"Sung J.Y.; Lee K.Y.; Kim J.R.; Choi H.C.; Interaction between mTOR pathway inhibition and autophagy induction attenuates adriamycin-induced vascular smooth muscle cell senescence through] decreased expressions of p53\/p21\/p16. Exp Gerontol 2018,109,51-58","journal-title":"Exp Gerontol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"E95","DOI":"10.3390\/metabo8040095","volume":"8","author":"You R.","year":"2018","unstructured":"You R.; Dai J.; Zhang P.; Barding G.A.; Raftery D.; Dynamic metabolic response to adriamycin-induced senescence in breast cancer cells. Metabolites 2018,8(4),E95","journal-title":"Metabolites"},{"key":"ref=14","author":"Song X.","year":"2018","unstructured":"Song X.; He R.; Han W.; Protective effects of the ROCK inhibitor fasudil against cognitive dysfunction following status epilepticus in male rats. J Neurosci Res 2018","journal-title":"J Neurosci Res"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/bcpt.12895","volume":"122","author":"Wang Y.","year":"2018","unstructured":"Wang Y.; Zhang H.; Yang Z.; Miao D.; Zhang D.; Rho kinase inhibitor, fasudil, attenuates contrast-induced acute kidney injury. Basic Clin Pharmacol Toxicol 2018,122(2),278-287","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s12012-019-09561-6","volume":"20","author":"Yan Y.","year":"2020","unstructured":"Yan Y.; Xiang C.; Yang Z.; Miao D.; Zhang D.; Rho kinase inhibition by fasudil attenuates adriamycin-induced chronic heart injury. Cardiovasc Toxicol 2020,20(4),351-360","journal-title":"Cardiovasc Toxicol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"e0223232","DOI":"10.1371\/journal.pone.0223232","volume":"14","author":"Zhao Y.","year":"2019","unstructured":"Zhao Y.; Zhang Y.; Vazirinejad Mehdiabad M.; Enhanced anti-tumor effect of liposomal Fasudil on hepatocellular carcinoma in vitro and in vivo. PLoS One 2019,14(10),e0223232","journal-title":"PLoS One"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.3389\/fphar.2018.01083","volume":"9","author":"Huang Y.Y.","year":"2018","unstructured":"Huang Y.Y.; Wu J.M.; Su T.; Zhang S.Y.; Lin X.J.; Fasudil, a rho-kinase inhibitor, exerts cardioprotective function in animal models of myocardial ischemia\/reperfusion injury: A meta-analysis and review of preclinical evidence and possible mechanisms. Front Pharmacol 2018,9,1083","journal-title":"Front Pharmacol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"6452","DOI":"10.1002\/jcb.26662","volume":"119","author":"Guan P.","year":"2018","unstructured":"Guan P.; Liang Y.; Wang N.; Fasudil alleviates pressure overload-induced heart failure by activating Nrf2-mediated antioxidant responses. J Cell Biochem 2018,119(8),6452-6460","journal-title":"J Cell Biochem"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.3892\/mmr.2014.2566","volume":"10","author":"Wu N.","year":"2014","unstructured":"Wu N.; Li W.; Shu W.; Lv Y.; Jia D.; Inhibition of Rho-kinase by fasudil restores the cardioprotection of ischemic postconditioninng in hypercholesterolemic rat heart. Mol Med Rep 2014,10(5),2517-2524","journal-title":"Mol Med Rep"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.lfs.2018.06.029","volume":"207","author":"Chen H.","year":"2018","unstructured":"Chen H.; Gao L.; Huang Z.; C1qTNF-related protein 1 attenuates doxorubicin-induced cardiac injury via activation of AKT. Life Sci 2018,207,492-498","journal-title":"Life Sci"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/S0140-6736(96)07015-8","volume":"349","author":"Anker S.D.","year":"1997","unstructured":"Anker S.D.; Ponikowski P.; Varney S.; Wasting as independent risk factor for mortality in chronic heart failure. Lancet 1997,349(9058),1050-1053","journal-title":"Lancet"},{"key":"ref=23","first-page":"202","volume":"50","author":"El-Boghdady N.A.","year":"2013","unstructured":"El-Boghdady N.A.; Increased cardiac endothelin-1 and nitric oxide in adriamycin-induced acute cardiotoxicity: Protective effect of Ginkgo biloba extract. Indian J Biochem Biophys 2013,50(3),202-209","journal-title":"Indian J Biochem Biophys"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1089\/jmf.2007.0715","volume":"12","author":"Mohamad R.H.","year":"2009","unstructured":"Mohamad R.H.; El-Bastawesy A.M.; Zekry Z.K.; The role of Curcuma longa against doxorubicin (adriamycin)-induced toxicity in rats. J Med Food 2009,12(2),394-402","journal-title":"J Med Food"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"3425","DOI":"10.3892\/etm.2018.5862","volume":"15","author":"Liu M.L.","year":"2018","unstructured":"Liu M.L.; Wang M.L.; Lv J.J.; Wei J.; Wan J.; Glibenclamide exacerbates adriamycin-induced cardiotoxicity by activating oxidative stress-induced endoplasmic reticulum stress in rats. Exp Ther Med 2018,15(4),3425-3431","journal-title":"Exp Ther Med"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1179\/1351000214Y.0000000088","volume":"19","author":"Aniss HA","year":"2014","unstructured":"Aniss HA; Said Ael M; El Sayed IH; Adly C; Amelioration of\nadriamycin-induced cardiotoxicity by Salsola kali aqueous extract\nis mediated by lowering oxidative stress. Redox report : Communications\nin free radical research 2014,19(4),170-8","journal-title":"Redox report : Communications\nin free radical research"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.numecd.2005.05.003","volume":"15","author":"Del Rio D.","year":"2005","unstructured":"Del Rio D.; Stewart A.J.; Pellegrini N.; A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr Metab Cardiovasc Dis 2005,15(4),316-328","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.5152\/akd.2011.003","volume":"11","author":"Ozdogan K","year":"2011","unstructured":"Ozdogan K; Taskin E; Dursun N; Protective effect of carnosine on\nadriamycin-induced oxidative heart damage in rats. Anadolu\nkardiyoloji dergisi: AKD = the Anatolian journal of cardiology 2011,11(1),3-10"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"549","DOI":"10.4103\/1673-5374.228761","volume":"13","author":"Zhang X.H.","year":"2018","unstructured":"Zhang X.H.; Feng Z.H.; Wang X.Y.; The ROCK pathway inhibitor Y-27632 mitigates hypoxia and oxidative stress-induced injury to retinal M\u00fcller cells. Neural Regen Res 2018,13(3),549-555","journal-title":"Neural Regen Res"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s11010-017-3086-x","volume":"436","author":"Liang J.","year":"2017","unstructured":"Liang J.; Zeng X.; Halifu Y.; Blocking RhoA\/ROCK inhibits the pathogenesis of pemphigus vulgaris by suppressing oxidative stress and apoptosis through TAK1\/NOD2-mediated NF-\u03baB pathway. Mol Cell Biochem 2017,436(1-2),151-158","journal-title":"Mol Cell Biochem"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"30515","DOI":"10.1074\/jbc.M113.489716","volume":"288","author":"Lee D.","year":"2013","unstructured":"Lee D.; Goldberg A.L.; SIRT1 protein, by blocking the activities of transcription factors FoxO1 and FoxO3, inhibits muscle atrophy and promotes muscle growth. J Biol Chem 2013,288(42),30515-30526","journal-title":"J Biol Chem"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"9705","DOI":"10.1007\/s11357-014-9705-5","volume":"36","author":"Lin C.H.","year":"2014","unstructured":"Lin C.H.; Lin C.C.; Ting W.J.; Resveratrol enhanced FOXO3 phosphorylation via synergetic activation of SIRT1 and PI3K\/Akt signaling to improve the effects of exercise in elderly rat hearts. Age (Dordr) 2014,36(5),9705","journal-title":"Age (Dordr)"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.cmet.2011.10.001","volume":"14","author":"Oka S.","year":"2011","unstructured":"Oka S.; Alcendor R.; Zhai P.; PPAR\u03b1-Sirt1 complex mediates cardiac hypertrophy and failure through suppression of the ERR transcriptional pathway. Cell Metab 2011,14(5),598-611","journal-title":"Cell Metab"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3892\/mmr.2013.1554","volume":"8","author":"Guo R.M.","year":"2013","unstructured":"Guo R.M.; Xu W.M.; Lin J.C.; Activation of the p38 MAPK\/NF-\u03baB pathway contributes to doxorubicin-induced inflammation and cytotoxicity in H9c2 cardiac cells. Mol Med Rep 2013,8(2),603-608","journal-title":"Mol Med Rep"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"H512","DOI":"10.1152\/ajpheart.00160.2018","volume":"315","author":"Kannappan R.","year":"2018","unstructured":"Kannappan R.; Mattapally S.; Wagle P.A.; Zhang J.; Transactivation domain of p53 regulates DNA repair and integrity in human iPS cells. Am J Physiol Heart Circ Physiol 2018,315(3),H512-H521","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s11596-012-0058-y","volume":"32","author":"He L","year":"2012","unstructured":"He L; Xiao J; Fu H; Effect of oxidative stress on ventricular\narrhythmia in rabbits with adriamycin-induced cardiomyopathy.\nJournal of Huazhong University of Science and Technology Medical\nsciences = Hua zhong ke ji da xue xue bao Yi xue Ying De\nwen ban = Huazhong keji daxue xuebao Yixue Yingdewen ban 2012,32(3),334-9"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s10238-011-0165-2","volume":"12","author":"Abd El-Aziz T.A.","year":"2012","unstructured":"Abd El-Aziz T.A.; Mohamed R.H.; Pasha H.F.; Abdel-Aziz H.R.; Catechin protects against oxidative stress and inflammatory-mediated cardiotoxicity in adriamycin-treated rats. Clin Exp Med 2012,12(4),233-240","journal-title":"Clin Exp Med"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1089\/ars.2015.6421","volume":"24","author":"Preau S.","year":"2016","unstructured":"Preau S.; Delguste F.; Yu Y.; Endotoxemia engages the RhoA kinase pathway to impair cardiac function by altering cytoskeleton, mitochondrial fission, and autophagy. Antioxid Redox Signal 2016,24(10),529-542","journal-title":"Antioxid Redox Signal"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1161\/01.CIR.0000127939.16111.58","volume":"109","author":"Hattori T.","year":"2004","unstructured":"Hattori T.; Shimokawa H.; Higashi M.; Long-term inhibition of Rho-kinase suppresses left ventricular remodeling after myocardial infarction in mice. Circulation 2004,109(18),2234-2239","journal-title":"Circulation"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"e47351","DOI":"10.1371\/journal.pone.0047351","volume":"7","author":"Lv X.","year":"2012","unstructured":"Lv X.; Yu X.; Wang Y.; Berberine inhibits doxorubicin-triggered cardiomyocyte apoptosis via attenuating mitochondrial dysfunction and increasing Bcl-2 expression. PLoS One 2012,7(10),e47351","journal-title":"PLoS One"},{"key":"ref=41","first-page":"4592","volume":"62","author":"Childs A.C.","year":"2002","unstructured":"Childs A.C.; Phaneuf S.L.; Dirks A.J.; Phillips T.; Leeuwenburgh C.; Doxorubicin treatment in vivo causes cytochrome C release and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase activity, and Bcl-2:Bax ratio. Cancer Res 2002,62(16),4592-4598","journal-title":"Cancer Res"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1159\/000491896","volume":"48","author":"Jing X","year":"2018","unstructured":"Jing X; Yang J; Jiang L; Chen J; Wang H.; MicroRNA-29b regulates\nthe mitochondria-dependent apoptotic pathway by targeting\nbax in doxorubicin cardiotoxicity. Cellular physiology and biochemistry\n: International journal of experimental cellular physiology,\nbiochemistry, and pharmacology 2018,48(2),692-704"},{"key":"ref=43","first-page":"222","volume":"33","author":"Bao YL","year":"2017","unstructured":"Bao YL; Wang Y; Wu Z; Effects of caspase inhibitor z-\nVAD-fmk on the expressions of calumenin, caspase-3, GRP78 and\nGRP94 in adriamycin-injured cardiomyocytes. Zhongguo ying\nyong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi =\nChinese journal of applied physiology 2017,33(3),222-5"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.jtcvs.2010.04.016","volume":"141","author":"Yanagi S.","year":"2011","unstructured":"Yanagi S.; Matsumura K.; Marui A.; Oral pretreatment with a green tea polyphenol for cardioprotection against ischemia-reperfusion injury in an isolated rat heart model. J Thorac Cardiovasc Surg 2011,141(2),511-517","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1161\/CIRCRESAHA.121.319901","volume":"130","author":"Wilcox N.S.","year":"2022","unstructured":"Wilcox N.S.; Rotz S.J.; Mullen M.; Sex-specific cardiovascular risks of cancer and its therapies. Circ Res 2022,130(4),632-651","journal-title":"Circ Res"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13293-018-0198-2","volume":"9","author":"Meiners B.","year":"2018","unstructured":"Meiners B.; Shenoy C.; Zordoky B.N.; Clinical and preclinical evidence of sex-related differences in anthracycline-induced cardiotoxicity. Biol Sex Differ 2018,9(1),38","journal-title":"Biol Sex Differ"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"F900","DOI":"10.1152\/ajprenal.00687.2012","volume":"304","author":"Ojeda N.B.","year":"2013","unstructured":"Ojeda N.B.; Royals T.P.; Alexander B.T.; Sex differences in the enhanced responsiveness to acute angiotensin II in growth-restricted rats: Role of fasudil, a Rho kinase inhibitor. Am J Physiol Renal Physiol 2013,304(7),F900-F907","journal-title":"Am J Physiol Renal Physiol"}],"container-title":["Current Pharmaceutical Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1381612828666220729103430","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/207106\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1381612828666220729103430","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T13:14:25Z","timestamp":1691673265000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/207106\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":47,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1381612828666220729103430","relation":{},"ISSN":["1381-6128"],"issn-type":[{"value":"1381-6128","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-02-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}